Insights

Gathering insights about Acumen…

Similar companies to Acumen

Acumen Tech Stack

Acumen uses 8 technology products and services including Facebook Pixel, WordPress, Font Awesome, and more. Explore Acumen's tech stack below.

Facebook Pixel
Analytics
WordPress
Content Management System
Font Awesome
Font Scripts
Swiper
Javascript Libraries
PWA
Miscellaneous
PHP
Programming Languages
Cloudflare Bot Management
Security
Nginx
Web Servers

Media & News

Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
The heavy selling pressure might have exhausted for Acumen Pharmaceuticals (ABOS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Mar 31, 2026 | www.zacks.com
Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?
Here is how Acumen Pharmaceuticals, Inc. (ABOS) and ADC Therapeutics SA (ADCT) have performed compared to their sector so far this year.
Mar 30, 2026 | www.zacks.com
Analysts Set Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Target Price at $7.00
Shares of Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS - Get Free Report) have been assigned a consensus rating of "Moderate Buy" from the four analysts that are presently covering the firm, Marketbeat reports. One equities research analyst has rated the stock with a sell recommendation and three have issued a buy recommendation on the company. The average
Mar 30, 2026 | www.defenseworld.net
Acumen Pharmaceuticals, Inc. (ABOS) Q4 2025 Earnings Call Transcript
Acumen Pharmaceuticals, Inc. (ABOS) Q4 2025 Earnings Call Transcript
Mar 26, 2026 | seekingalpha.com
Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights
NEWTON, Mass., March 26, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer's disease (AD), today reported financial results for the full year ended December 31, 2025 and provided a business update.
Mar 26, 2026 | www.globenewswire.com
Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026
NEWTON, Mass., March 19, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer's disease, today announced that the Company will report fourth quarter and year-end 2025 financial results on Thursday, March 26, 2026. The Company will host a conference call and live audio webcast at 8:00 a.m. ET to provide a business and financial update.
Mar 19, 2026 | www.globenewswire.com
Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio
NEWTON, Mass., March 16, 2026 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid b oligomers (AβOs) for the treatment of Alzheimer's disease (AD), today announced that it has entered into a securities purchase agreement with certain institutional and accredited investors for a private placement of approximately $35.75 million of shares of its common stock at a price of $3.30 per share. Acumen expects to receive gross proceeds from the offering of approximately $35.75 million, before deducting offering expenses.
Mar 16, 2026 | www.globenewswire.com

Acumen's Email Address Formats

Acumen uses at least 1 format(s):

Acumen Email Formats	Example	Percentage
First.Last@acumen.be	John.Doe@acumen.be	84%
First.MiddleLast@acumen.be	John.MichaelDoe@acumen.be	7%
First@acumen.be	John@acumen.be	7%
First.Middle.Last@acumen.be	John.Michael.Doe@acumen.be	2%

Frequently Asked Questions

Where is Acumen's headquarters located?

Acumen's main headquarters is located at 14 Ambachtenlaan Heverlee, Flanders 3001 Belgium. The company has employees across 4 continents, including EuropeSouth AmericaNorth America.

What is Acumen's stock symbol?

Acumen is a publicly traded company; the company's stock symbol is ABOS.

What is Acumen's official website and social media links?

Acumen's official website is acumen.be and has social profiles on LinkedIn.

What is Acumen's SIC code NAICS code?

Acumen's SIC code is 7372 - Prepackaged Software NAICS code is 518 - Data Processing, Hosting, and Related Services.

How many employees does Acumen have currently?

As of April 2026, Acumen has approximately 71 employees across 4 continents, including EuropeSouth AmericaNorth America. Key team members include President: R. Y.Partner: B. V. W.Partner: B. W.. Explore Acumen's employee directory with LeadIQ.

What industry does Acumen belong to?

Acumen operates in the Data Infrastructure and Analytics industry.

What technology does Acumen use?

Acumen's tech stack includes Facebook PixelWordPressFont AwesomeSwiperPWAPHPCloudflare Bot ManagementNginx.

What is Acumen's email format?

Acumen's email format typically follows the pattern of First.Last@acumen.be. Find more Acumen email formats with LeadIQ.

When was Acumen founded?

Acumen was founded in 2007.

Acumen

Q: What is Acumen's official website and social media links?

Acumen's official website is acumen.be. Acumen has social profiles on LinkedIn.

Q: How many employees does Acumen have currently?

Acumen has approximately 71 employees.

Q: What technology does Acumen use?

Acumen's tech stack includes Twemoji, Google Cloud, jsDelivr, Chart.js, Modernizr.

Q: What is Acumen's NAICS code?

Acumen's NAICS code is 518 (Data Processing, Hosting, and Related Services).

Data Infrastructure and AnalyticsFlanders, Belgium51-200 Employees

Turning data into smarter decisions.

Company Overview

Headquarters: 14 Ambachtenlaan Heverlee, Flanders 3001 Belgium
Website: acumen.be
SIC Code: 7372 - Prepackaged Software
Stock Symbol: ABOS
NAICS Code: 518 - Data Processing, Hosting, and Related Services
Founded: 2007
Employees: 51-200

Media & News

Funding & Financials

$1M$10M
Acumen's revenue is estimated to be in the range of $1M$10M

Funding & Financials

$1M$10M
Acumen's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

Insights

Similar companies to Acumen

Schwab Foundation for Social Entrepreneurship

Skoll Foundation

Echoing Green

Gates Foundation

New Profit

Kiva

Draper Richards Kaplan Foundation

Acumen Tech Stack

Media & News

Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?

Analysts Set Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Target Price at $7.00

Acumen Pharmaceuticals, Inc. (ABOS) Q4 2025 Earnings Call Transcript

Acumen Pharmaceuticals Reports Financial Results for the Year Ended December 31, 2025 and Business Highlights

Acumen Pharmaceuticals to Report Fourth Quarter and Year-End 2025 Financial Results on March 26, 2026

Acumen Pharmaceuticals Announces $35.75 Million Private Placement to Advance Potential Best-in-Class Molecules from Amyloid Beta Oligomer-Selective Enhanced Brain Delivery Portfolio

Acumen's Email Address Formats

Frequently Asked Questions

Where is Acumen's headquarters located?

What is Acumen's stock symbol?

What is Acumen's official website and social media links?

What is Acumen's SIC code NAICS code?

How many employees does Acumen have currently?

What industry does Acumen belong to?

What technology does Acumen use?

What is Acumen's email format?

When was Acumen founded?

Acumen

Company Overview

Media & News

Acumen Pharmaceuticals (ABOS) Loses 33.6% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Is Acumen Pharmaceuticals (ABOS) Stock Outpacing Its Medical Peers This Year?

Analysts Set Acumen Pharmaceuticals, Inc. (NASDAQ:ABOS) Target Price at $7.00

Funding & Financials

Funding & Financials

Company Leadership

Employee Directory

Ready to create more pipeline?

Ready to create more pipeline?